Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.81 |
| ▸ | ACHE | P22303 | 2/20 | 0.81 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | CA12 | O43570 | 5/20 | 0.56 |
| ▸ | CA1 | P00915 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 5/20 | 0.56 |
| ▸ | CA7 | P43166 | 5/20 | 0.56 |
| ▸ | CA9 | Q16790 | 5/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | RECQL | P46063 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Orsellinate SCHEMBL370816 | 0.90 | CYP3A4 (1.00) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL20503232 | 0.86 | CYP3A4 (0.68) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL23484417 | 0.86 | CYP3A4 (0.68) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL1036031 | 0.84 | CYP3A4 (0.59) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL2662948 | 0.82 | CYP3A4 (0.62) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL70139 | 0.82 | CYP3A4 (0.57) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL28768602 | 0.81 | CYP3A4 (0.61) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL10073228 | 0.80 | CYP3A4 (0.55) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL610098 | 0.80 | CYP3A4 (0.55) | CYP3A4ACHEHPGDCA12CA1 | |
| SCHEMBL11067587 | 0.80 | CYP3A4 (0.79) | CYP3A4ACHEHPGDCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113748021-B | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2024-07-05 | — | — | CN | claimed |
| US-12630510-B2 | EP2 antagonist | ONO PHARMACEUTICAL CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| CN-122060466-A | Comb type polymer modified barite powder and preparation method and application thereof | 中国石油集团渤海钻探工程有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12486258-B2 | Compounds and methods for regulating insulin secretion | THE BROAD INSTITUTE, INC. (US) | 2025-12-02 | — | — | US | disclosed |
| US-12421452-B2 | Method for producing liquid-crystal polyester processed product | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-3992176-B1 | EP2 ANTAGONIST | ONO PHARMACEUTICAL CO (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20250228811-A1 | Triester Compounds And Methods Of Use Thereof | LIFEMINE THERAPEUTICS, INC. | 2025-07-17 | — | — | US | disclosed |
| CN-113748021-B | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2024-07-05 | — | — | CN | disclosed |
| US-20240084196-A1 | METHOD FOR PRODUCING LIQUID-CRYSTAL POLYESTER PROCESSED PRODUCT | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| US-11884864-B2 | Method for producing liquid-crystal polyester processed product | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-01-30 | — | — | US | disclosed |
| EP-0594257-B1 | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | STERLING WINTHROP INC (US) | 1996-07-10 | — | — | EP | disclosed |
| US-5512589-A | TREATING DEGENERATIVE DISEASES | STERLING WINTHROP INC. (US) | 1996-04-30 | — | — | US | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| EP-0594257-A1 | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | STERLING WINTHROP INC. (US) | 1994-04-27 | — | — | EP | disclosed |
| US-5306818-A | Treating degenerative diseases such as emphysema, rheumatoid arthritis and pancreatitis | STERLING WINTHROP INC. (US) | 1994-04-26 | — | — | US | disclosed |
| US-5157018-A | Phenolic resins; for waterless offset printing plates | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-20 | — | — | US | disclosed |
| US-5104961-A | Waterless offset printing | HOECHST CELANESE CORPORATION (US) | 1992-04-14 | — | — | US | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-5006443-A | Radiation sensitive reproduction composition and element with perfluoroalkyl group containing polymer | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-04-09 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486258-B2 | Compounds and methods for regulating insulin secretion | IAPP, GPR119, PNLIP | CYP3A4 4626/4885ACHE 3202/4885HPGD 2210/4885 |
| US-12630510-B2 | EP2 antagonist | PTGER2, PTGER1, PTGER4 | CYP3A4 1190/4885ACHE 3231/4885HPGD 1044/4885 |
| US-20250228811-A1 | Triester Compounds And Methods Of Use Thereof | CYP46A1, CYP17A1, CYP27A1 | CYP3A4 104/4885ACHE 1179/4885HPGD 815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.